Methylphenidate for attention-deficit/hyperactivity disorder in patients with Smith-Magenis syndrome: protocol for a series of N-of-1 trials.

Müller AR, Zinkstok JR, Rommelse NNJ, van de Ven PM, Roes KCB, Wijburg FA, de Rooij-Askes E, Linders C, Boot E, van Eeghen AM

Open source

DOI
10.1186/s13023-021-02003-z
Published
2021 Sep 8
Container
Orphanet journal of rare diseases
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13023-021-02003-z,
  title = {Methylphenidate for attention-deficit/hyperactivity disorder in patients with Smith-Magenis syndrome: protocol for a series of N-of-1 trials.},
  author = {Müller AR and Zinkstok JR and Rommelse NNJ and van de Ven PM and Roes KCB and Wijburg FA and de Rooij-Askes E and Linders C and Boot E and van Eeghen AM},
  year = {2021},
  journal = {Orphanet journal of rare diseases},
  doi = {10.1186/s13023-021-02003-z},
  url = {https://doi.org/10.1186/s13023-021-02003-z}
}

RIS

TY  - JOUR
TI  - Methylphenidate for attention-deficit/hyperactivity disorder in patients with Smith-Magenis syndrome: protocol for a series of N-of-1 trials.
AU  - Müller AR
AU  - Zinkstok JR
AU  - Rommelse NNJ
AU  - van de Ven PM
AU  - Roes KCB
AU  - Wijburg FA
AU  - de Rooij-Askes E
AU  - Linders C
AU  - Boot E
AU  - van Eeghen AM
PY  - 2021
JO  - Orphanet journal of rare diseases
DO  - 10.1186/s13023-021-02003-z
UR  - https://doi.org/10.1186/s13023-021-02003-z
ER  - 

APA

AR, M., JR, Z., NNJ, R., PM, V. D. V., KCB, R., FA, W., E, D. R., C, L., E, B., & AM, V. E. (2021). Methylphenidate for attention-deficit/hyperactivity disorder in patients with Smith-Magenis syndrome: protocol for a series of N-of-1 trials.. Orphanet journal of rare diseases. https://doi.org/10.1186/s13023-021-02003-z

Source records